Showing results (191-200 of 946) with videos related to
Sort By:
Pageof 95
Neurology|October 1, 1995
Levodopa-induced dyskinesias are improved by fluoxetineF Durif, M Vidailhet, A M Bonnet, et al.Journal of Inherited Metabolic Disease|June 20, 2008
Movement disorders and inborn errors of metabolism in adults: a diagnostic approachF Sedel, J-M Saudubray, E Roze, et al.Brain Research|February 21, 1997
The density of [125I]-transferrin binding sites on perikarya of melanized neurons of the substantia nigra is decreased in Parkinson's diseaseB A Faucheux, J J Hauw, Y Agid, et al.Brain Research|January 1, 1986
Acetylcholinesterase and butyrylcholinesterase in frontal cortex and cerebrospinal fluid of demented and non-demented patients with Parkinson's diseaseM Ruberg, F Rieger, A Villageois, et al.The Journal of Comparative Neurology|October 12, 1999
Dopaminergic cell group A8 in the monkey: anatomical organization and projections to the striatumC François, J Yelnik, D Tandé, et al.Molecular and Chemical Neuropathology|May 1, 1996
Neurotrophin receptors and selective loss of cholinergic neurons in Alzheimer diseaseF Boissière, S Lehéricy, O Strada, et al.Neuroscience|August 1, 1996
Increased M-calpain expression in the mesencephalon of patients with Parkinson's disease but not in other neurodegenerative disorders involving the mesencephalon: a role in nerve cell death?A Mouatt-Prigent, J O Karlsson, Y Agid, et al.Journal of Neurochemistry|April 1, 1983
Striatal GABAergic neuronal activity is not reduced in Parkinson's diseaseT L Perry, F Javoy-Agid, Y Agid, et al.Journal of Neurochemistry|April 27, 1999
Adenosine prevents the death of mesencephalic dopaminergic neurons by a mechanism that involves astrocytesP P Michel, M Marien, M Ruberg, et al.Brain Research|March 5, 1999
Mechanisms of apoptosis in PC12 cells irreversibly differentiated with nerve growth factor and cyclic AMPN Lambeng, P P Michel, B Brugg, et al.Pageof 95